Login to Your Account



Clinic Roundup


Friday, July 19, 2013
• Genmab A/S, of Copenhagen, Denmark, said it filed a new drug application to start a Phase I dose-escalation trial of HuMax-TF-ADC to treat multiple solid tumors.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription